Cargando…
New Angiogenic Regulators Produced by TAMs: Perspective for Targeting Tumor Angiogenesis
SIMPLE SUMMARY: Since the targeting of a single pro-angiogenic factor fails to improve oncological disease outcome, significant efforts have been made to identify new pro-angiogenic factors that could compensate for the deficiency of current therapy or act independently as single drugs. Our review a...
Autores principales: | Larionova, Irina, Kazakova, Elena, Gerashchenko, Tatiana, Kzhyshkowska, Julia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268686/ https://www.ncbi.nlm.nih.gov/pubmed/34209679 http://dx.doi.org/10.3390/cancers13133253 |
Ejemplares similares
-
YKL-39 as a Potential New Target for Anti-Angiogenic Therapy in Cancer
por: Kzhyshkowska, Julia, et al.
Publicado: (2020) -
Macrophage scavenger receptors: Tumor support and tumor inhibition
por: Kazakova, Elena, et al.
Publicado: (2023) -
Transcriptional, Epigenetic and Metabolic Programming of Tumor-Associated Macrophages
por: Larionova, Irina, et al.
Publicado: (2020) -
Interaction of tumor-associated macrophages with stromal and immune components in solid tumors: Research progress (Review)
por: Kazakova, Anna, et al.
Publicado: (2023) -
Angiogenesis regulators S100A4, SPARC and SPP1 correlate with macrophage infiltration and are prognostic biomarkers in colon and rectal cancers
por: Kazakova, Elena, et al.
Publicado: (2023)